JPRN-UMIN000035771已完成未知
Efficacy and safety of vibegron for treating overactive bladder: a prospective real-world study - Efficacy and safety of vibegron
Department of Urology, Sapporo Medical University School of Medicine0 个研究点目标入组 212 人开始时间: 2019年2月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 212
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •the patient with allergy to beta 3 agonists
研究者
相似试验
招募中
Unknown
Study of additional vibegron in persistent overactive bladderoveractive bladderJPRN-jRCTs031230450Yoshida Masaki160
招募中
4 期
Prospective clinical study of switch to vibegron for overactive bladder patients with inadequate effect of antimuscarinics and mirabegron treatmentJPRN-jRCT1071230070Imamura Ryoichi30
招募中
4 期
Comparison of vibegron and mirabegron in the treatment of female over active bladder subjects: A randomized, prospective studyoveractive bladderJPRN-UMIN000038288Department of urology, Hokusuikai Kinen Hospital100
招募中
4 期
Safety and efficacy of mirabegron on nocturia and quality of sleep in Japanese patients with overactive bladder.overactive bladderJPRN-UMIN000012869Fujita Health University100
已完成
不适用
Effectiveness and Safety of Vibegron in Patients with Overactive Bladder: A Retrospective Chart Review of Patient Outcomesoveractive bladderJPRN-UMIN000037233ishino Clinic, Koseikai Medical Corp.100
